Avanish Vellanki, Chairman and CEO at Rain Therapeutics Inc. (RAIN), bought 25,000 shares at $2.29 ($57K) on 2022-06-01, disclosed to the SEC on 2022-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.